Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

TCT 2021

Latest videos from TCT 2021

View all
0:52
Developments in the treatment of myeloma
Mahmoud Gaballa • 5 Feb 2021
2:44
TCT 2021: narsoplimab in TA-TMA
Eleni Gavriilaki • 2 Feb 2021
3:40
Relationship between IL-15 serum concentrations & CD19 CAR T-cell therapy
Jordan Gauthier • 28 Jan 2021
4:55
Long-term outcomes of VRD, auto-HCT with Mel200 conditioning & lenalidomide maintenance in MM
Mahmoud Gaballa • 5 Feb 2021

Transplantation

View all
2:44
TCT 2021: narsoplimab in TA-TMA
Eleni Gavriilaki • 2 Feb 2021
4:55
Long-term outcomes of VRD, auto-HCT with Mel200 conditioning & lenalidomide maintenance in MM
Mahmoud Gaballa • 5 Feb 2021
4:33
Impact of COVID-19 on HSCT and cellular therapies in the US
Katie Maurer • 2 Feb 2021
2:56
Clinical presentation & outcomes of COVID-19 following HCT
Jose F. Camargo • 5 Feb 2021

CAR-T & Cellular Therapy

View all
0:52
Developments in the treatment of myeloma
Mahmoud Gaballa • 5 Feb 2021
3:40
Relationship between IL-15 serum concentrations & CD19 CAR T-cell therapy
Jordan Gauthier • 28 Jan 2021
4:33
Impact of COVID-19 on HSCT and cellular therapies in the US
Katie Maurer • 2 Feb 2021
1:38
Learnings of COVID-19 on transplant and cellular therapies
Katie Maurer • 5 Feb 2021
The content of VJHemOnc is intended for healthcare professionals